Evidence map›Paper›PMID 18820594›Full record

ArticlePharmacogenetics and genomics2008

Mitochondrial tRNAThr G15927A mutation may modulate the phenotypic manifestation of ototoxic 12S rRNA A1555G mutation in four Chinese families.

Xinjian Wang, Jianxin Lu, Yi Zhu, Aifen Yang, Li Yang, Ronghua Li, Bobei Chen, Yaping Qian, Xiaowen Tang, Jindan Wang and 2 more

Open access · greenAbstract read
In one paragraph

Article in Pharmacogenetics and genomics, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Contribution of the tRNAThe Journal of biological chemistry · 2018
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Mitochondrial ribosome and Ménière's disease: a pilot study.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2012
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Xinjian WangDivision of Human Genetics, Cincinnati Children's Hospital Medical Center Cincinnati, Ohio 45229-3039, USA.
Jianxin Lu
Yi Zhu
Aifen Yang
Li Yang
Ronghua Li
Bobei Chen
Yaping Qian
Xiaowen Tang
Jindan Wang
Xue Zhang
Min-Xin Guan
Laboratoire de Génétique MédicaleCincinnati Children's Hospital Medical Center · USPeking Union Medical College Hospital · CNUniversity of Cincinnati Medical Center · USWenzhou Medical University · CN

Funding

Molecular Mechanism of Aminoglycoside OtotoxicityR01DC005230 · NIDCD · CINCINNATI CHILDRENS HOSP MED CTR · PI GUAN, MIN-XIN · 2002 to 2006
$1.8M
Nuclear modifier genes for maternally inherited deafnessR01DC007696 · NIDCD · CINCINNATI CHILDRENS HOSP MED CTR · PI GUAN, MIN-XIN · 2007 to 2010
$1.3M
NIDCD NIH HHS R01 DC005230NIDCD NIH HHS R01 DC007696NIDCD NIH HHS R01DC05230NIDCD NIH HHS R01DC07696
6 · The paper itself

Abstract

objectiveTo investigate the role of mitochondrial modifiers in the development of deafness associated with 12S rRNA A1555G mutation.

methodsFour Chinese families with nonsyndromic and aminoglycoside-induced deafness were studied by clinical and genetic evaluation, molecular and biochemical analyses of mitochondrial DNA (mtDNA).

resultsThese families exhibited high penetrance and expressivity of hearing impairment. Penetrances of hearing loss in WZD31, WZD32, WZD33, and WZD34 pedigrees ranged from 50 to 67% and from 39 to 50%, respectively, when aminoglycoside-induced hearing loss was included or excluded. Matrilineal relatives in these families developed hearing loss at the average of 14, 13, 16, and 15 years of age, respectively, when aminoglycoside-induced deafness was excluded. Mutational analysis of entire mtDNA in these families showed the homoplasmic A1555G mutation and distinct sets of variants belonging to haplogroup B5b1. Of these, the tRNA G15927A mutation locates at the fourth base in the anticodon stem (conventional position 42) of tRNA. A guanine (G42) at this position of tRNA is highly conserved from bacteria to human mitochondria. The lower levels and altered electrophoretic mobility of tRNA were observed in cells carrying A1555G and G15927A mutations or only G15927A mutation but not cells carrying only A1555G mutation. The abolished base pairing (28C-42G) of this tRNA by the G15927A mutation caused a failure in tRNA metabolism, worsening the mitochondrial dysfunctions altered by the A1555G mutation.

conclusionThe G15927A mutation has a potential modifier role in increasing the penetrance and expressivity of the deafness-associated 12S rRNA A1555G mutation in those Chinese pedigrees.

Indexed as

AdenineAminoacylationAminoglycosidesAsian PeopleBase SequenceCell LineChinaConnexin 26ConnexinsDeafnessDNA Mutational AnalysisFamilyFemaleGenome, MitochondrialGuanineHearing TestsAdenineAminoglycosidesConnexin 26ConnexinsGuanineMitochondrial ProteinsRNA, RibosomalRNA, ribosomal, 12SRNA, Transfer, ThrTRMU protein, humantRNA Methyltransferases

Identifiers

PMID18820594
PMCPMC2905378
OpenAlexW2026289475

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.